Progress in the development of selective nitric oxide synthase (NOS) inhibitors.

@article{Salerno2002ProgressIT,
  title={Progress in the development of selective nitric oxide synthase (NOS) inhibitors.},
  author={L. Salerno and V. Sorrenti and C. Di Giacomo and G. Romeo and M. Siracusa},
  journal={Current pharmaceutical design},
  year={2002},
  volume={8 3},
  pages={
          177-200
        }
}
Nitric oxide (NO), a molecular messenger synthesized by nitric oxide synthase (NOS) from L-arginine and molecular oxygen, is involved in a number of physiological and pathological processes in mammalians. Three structurally distinct isoforms of NOS have been identified: neuronal (nNOS), endothelial (eNOS) and inducible (iNOS). Although NO mediates several physiological functions, overproduction of NO by nNOS has been reported in a number of clinical disorders including acute (stroke) and… Expand
204 Citations
Inducible nitric oxide synthase inhibitors: A comprehensive update
  • 3
Novel Nitric Oxide Synthase (NOS) Inhibitors: a Patent Review
Nitric Oxide Synthase Inhibition
  • 28
Pharmacologic manipulation of nitric oxide signaling: targeting NOS dimerization and protein-protein interactions.
  • 50
Inducible nitric oxide synthase (iNOS): role in asthma pathogenesis.
  • 26
  • PDF
Novel nitric oxide synthase inhibitors: a patent review
  • 38
l-Arginine Chlorination Results in the Formation of a Nonselective Nitric-Oxide Synthase Inhibitor
  • 17
  • PDF
...
1
2
3
4
5
...